Natasja de Bruin

Dr. Natasja de Bruin

benfovir AG, Darmstadt, Hesse, Germany
orcid
R&D Project Manager / benfovir AG

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SSSisignanoMarco Sisignano
SisignanoMarco Sisignano
CACarlo Angioni
Carlo Angioni
CPChul-Kyu Park
Chul-Kyu Park
SSSascha Meyer Dos Santos
Sascha Meyer Dos Santos
HJHolger Jordan
Holger Jordan
GGGerd Geisslinger
Gerd Geisslinger
Significance: Chemotherapy-induced peripheral neuropathic pain (CIPNP) is a severe side effect that affects up to 80% of patients during cancer treatment. Pharmacological treatment options are poor, as CIPNP differs mechanistically from other chronic pain states. Here, we describe a mechanism by which pronociceptive oxidized lipid mediators are generated by the cytochrome P 450 -epoxygenase CYP2J2 in sensory neurons during CIPNP. Blocking the synthesis of these oxidized lipids with telmisartan, which we identified as a potent CYP2J2 inhibitor in a large drug repurposing screen, caused a robust reduction of paclitaxel-induced pain in mice in vivo. We therefore consider targeting CYP2J2 with telmisartan as a treatment option for chemotherapy-induced peripheral neuropathic pain in patients.

1 April 2019 in Cell Reports
Verified
Journal Article
Open access
YHYingying Han
Yingying Han
JMJavier Mora
Javier Mora
AHArnaud Huard
Arnaud Huard
PSPriscila da Silva
Priscila da Silva
SWSvenja Wiechmann
Svenja Wiechmann
Andreas WeigertAndreas Weigert
Andreas Weigert
Interleukin-38 (IL-38) is a cytokine of the IL-1 family with a role in chronic inflammation. However, its main cellular targets and receptors remain obscure. IL-38 is highly expressed in the skin and downregulated in psoriasis patients. We report an investigation in cellular targets of IL-38 during the progression of imiquimod-induced psoriasis. In this model, IL-38 knockout (IL-38 KO) mice show delayed disease resolution with exacerbated IL-17-mediated inflammation, which is reversed by the administration of mature IL-38 or γδ T cell-receptor-blocking antibodies. Mechanistically, X-linked IL-1 receptor accessory protein-like 1 (IL1RAPL1) is upregulated upon γδ T cell activation to feedforward-amplify IL-17 production and is required for IL-38 to suppress γδ T cell IL-17 production. Accordingly, psoriatic IL1RAPL1 KO mice show reduced inflammation and IL-17 production by γδ T cells. Our findings indicate a role for IL-38 in the regulation of γδ T cell activation through IL1RAPL1, with consequences for auto-inflammatory disease.


1 July 2003 in Neurobiology of Learning and Memory
Verified
Journal Article
Closed access
Natasja de BruinNatasja de Bruin
Natasja de Bruin
AKA.J Kiliaan
A.J Kiliaan
MWM.C De Wilde
M.C De Wilde
LBL.M Broersen
L.M Broersen

21 January 2015 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
RLRuirui Lu
Ruirui Lu
ABAnne E. Bausch
Anne E. Bausch
WKWiebke Kallenborn-Gerhardt
Wiebke Kallenborn-Gerhardt
CSCarsten Stoetzer
Carsten Stoetzer
Natasja de BruinNatasja de Bruin
Natasja de Bruin
ASAchim Schmidtko
Achim Schmidtko
Slack (Slo2.2) is a sodium-activated potassium channel that regulates neuronal firing activities and patterns. Previous studies identified Slack in sensory neurons, but its contribution to acute and chronic painin vivoremains elusive. Here we generated global and sensory neuron-specific Slack mutant mice and analyzed their behavior in various animal models of pain. Global ablation of Slack led to increased hypersensitivity in models of neuropathic pain, whereas the behavior in models of inflammatory and acute nociceptive pain was normal. Neuropathic pain behaviors were also exaggerated after ablation of Slack selectively in sensory neurons. Notably, the Slack opener loxapine ameliorated persisting neuropathic pain behaviors. In conclusion, Slack selectively controls the sensory input in neuropathic pain states, suggesting that modulating its activity might represent a novel strategy for management of neuropathic pain.

18 February 1999 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
Natasja de BruinNatasja de Bruin
Natasja de Bruin
Bart EllenbroekBart Ellenbroek
Bart Ellenbroek
ACA. R. Cools
A. R. Cools
ACA. M. L. Coenen
A. M. L. Coenen
ELE. L. J. M. van Luijtelaar
E. L. J. M. van Luijtelaar